Kamiya Kazutaka, Igarashi Akihito, Hayashi Ken, Negishi Kazuno, Sato Masaki, Bissen-Miyajima Hiroko
J Refract Surg. 2017 Sep 1;33(9):598-602. doi: 10.3928/1081597X-20170621-01.
To retrospectively evaluate the current practice, trends, and outcomes of refractive surgery in Japan.
This multicenter survey comprised 78,248 eyes of 39,727 consecutive patients who underwent refractive surgery at 45 major institutions in Japan. The corresponding ophthalmologists responded to a selfadministered questionnaire. The authors especially evaluated the safety, efficacy, predictability, stability, and adverse events of LASIK and phakic intraocular lens (IOL) implantation 3 months postoperatively.
The most common refractive surgery was LASIK (90.9%), followed by corneal inlay (5.0%), posterior chamber phakic IOL implantation (1.3%), laser-assisted subepithelial keratomileusis (1.0%), refractive lens exchange (0.9%), photorefractive keratectomy (0.3%), and refractive lenticule extraction (0.2%). For subgroup analysis, 69,987 eyes (99.5%) and 67,512 eyes (95.9%) achieved corrected and uncorrected distance visual acuity of 20/20 or better, respectively, after LASIK, and 935 eyes (98.8%) and 890 eyes (94.1%), respectively, after phakic IOL implantation. There were 69,176 eyes (98.3%) and 908 eyes (96.0%) within ±1.00 diopter (D) of the attempted correction after LASIK and phakic IOL implantation, respectively. There were 1,926 eyes (2.7%) and 1 eye (0.1%) with changes in refraction of 1.00 D or less from 1 week to 3 months after LASIK and phakic IOL implantation, respectively. No vision-threatening complications occurred in any case.
According to this survey, LASIK remains the most prevalent surgical technique in Japan. Both LASIK and phakic IOL implantation offered good safety and efficacy outcomes, yielding predictable and stable results. [J Refract Surg. 2017;33(9):598-602.].
回顾性评估日本屈光手术的当前实践、趋势及结果。
这项多中心调查纳入了日本45家主要机构连续接受屈光手术的39,727例患者的78,248只眼。相应的眼科医生对一份自填式问卷进行了回复。作者特别评估了LASIK和有晶状体眼人工晶状体(IOL)植入术后3个月的安全性、有效性、可预测性、稳定性及不良事件。
最常见的屈光手术是LASIK(90.9%),其次是角膜镶嵌术(5.0%)、后房型有晶状体眼IOL植入术(1.3%)、准分子激光上皮下角膜磨镶术(1.0%)、屈光性晶状体置换术(0.9%)、准分子激光角膜切削术(0.3%)和屈光性晶状体切除术(0.2%)。亚组分析显示,LASIK术后分别有69,987只眼(99.5%)和67,512只眼(95.9%)达到矫正和未矫正远视力20/20或更好,有晶状体眼IOL植入术后分别为935只眼(98.8%)和890只眼(94.1%)。LASIK和有晶状体眼IOL植入术后分别有69,176只眼(98.3%)和908只眼(96.0%)在预期矫正度数±1.00屈光度(D)范围内。LASIK和有晶状体眼IOL植入术后分别有1,926只眼(2.7%)和1只眼(0.1%)在术后1周与3个月之间屈光度变化≤1.00 D。所有病例均未发生威胁视力的并发症。
根据本次调查,LASIK仍是日本最普遍的手术技术。LASIK和有晶状体眼IOL植入术均具有良好的安全性和有效性结果,结果可预测且稳定。[《屈光手术杂志》。2017;33(9):598 - 602。]